New drug cocktail shows promise for tough lung cancer
NCT ID NCT05386888
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 35 times
Summary
This study tested whether adding two drugs, GFH018 and toripalimab, to standard chemoradiation helps shrink tumors in people with stage III lung cancer that cannot be removed by surgery. 65 adults with newly diagnosed, locally advanced non-small cell lung cancer took part. The main goal was to see how many patients had their tumors shrink or disappear after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC, STAGE III are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610000, China
Conditions
Explore the condition pages connected to this study.